{"id":5077,"date":"2024-06-27T01:02:44","date_gmt":"2024-06-27T00:02:44","guid":{"rendered":"http:\/\/www.trendsandtargets.com\/?p=5077"},"modified":"2024-06-27T01:02:44","modified_gmt":"2024-06-27T00:02:44","slug":"avacta-group-plc-lseavct-around-45-at-time-of-writing","status":"publish","type":"post","link":"http:\/\/www.trendsandtargets.com\/index.php\/2024\/06\/27\/avacta-group-plc-lseavct-around-45-at-time-of-writing\/","title":{"rendered":"Avacta Group Plc (LSE:AVCT) around 45 at time of writing"},"content":{"rendered":"

#Gold #Nasdaq\u00a0<\/b>\u00a0Something quite distressing seems to be taking place with cancers. As a child, there was a “bogeyman” number tossed around by the media which suggested 1 in 10 people could experience cancer. Through the years, this was modified to 1 in 5, then 1 in 3 and now 1 in 2 folk will get to enjoy the gentle hands of the treatment industry. A chum was visiting today and once we agreed neither of us would probably vote in the coming election, talk turned to how friends were doing. Cutting a long story short, it quickly started to feel like 1 in 2 may be a gross understatement, identifying friends who have not had a cancer scare becoming quite difficult! Perhaps it’s a West of Scotland thing but once you get over 50, it starts to feel like an invisible timer starts.<\/span><\/p>\n

Thankfully, as someone whose timer went off 12 years ago, I’ve become fairly flippant about chemotherapy and also become increasingly impressed with how “relatively easy” it is to get through, when compared with my six months of hell back in 2012. For this reason, I’m always fascinated by frontline life sciences companies such as Avacta and their constant battle to produce something new, effective, and priced properly. Avacta touch upon this with the statement on their website; “Avacta seeks to create long-term shareholder value alongside patient benefit<\/b>.<\/i>“<\/span><\/p>\n

The only problem with Avacta has been their dreadful share price history…<\/span><\/p>\n

 <\/p>\n

There’s a visual impression the recent visit to the 39p level shall maybe be regarded as a “double bottom”, matching the lows of 2022. There are early signs this may be the case, the share price recently breaking though the downtrend since October last year. The current situation suggests movements in the near term above 51.3 should trigger price recovery to 57.6p. If bettered, our longer term secondary is more interesting, calculating at 68.2p and giving the potential of the share price regaining the Red uptrend since 2020. Generally, this is a pretty reliable signal for better times ahead, so hopefully the company have some miracles waiting to be revealed.<\/span><\/p>\n

While the share price is no long a falling knife, there’s still the unlikely risk of below 39p bringing a visit to 30p with secondary, if broken, at 15p.<\/span><\/p>\n

<\/p>\n

 <\/p>\n

\n

FUTURES<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n
Time Issued<\/span><\/td>\nMarket<\/span><\/td>\nPrice At Issue<\/span><\/td>\nShort Entry<\/span><\/td>\nFast Exit<\/span><\/td>\nSlow Exit<\/span><\/td>\nStop<\/span><\/td>\nLong Entry<\/span><\/td>\nFast Exit<\/span><\/td>\nSlow Exit<\/span><\/td>\nStop<\/span><\/td>\nPrior<\/span><\/td>\n<\/tr>\n
10:27:12PM<\/span><\/td>\nBRENT<\/span><\/td>\n8448<\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
10:30:49PM<\/span><\/td>\nGOLD<\/span><\/td>\n2297.92<\/span><\/td>\n2294<\/span><\/td>\n2292<\/span><\/td>\n2282<\/span><\/td>\n2304<\/span><\/td>\n2322<\/span><\/td>\n2330<\/span><\/td>\n2342<\/span><\/td>\n2311<\/span><\/td>\n‘cess<\/span><\/td>\n<\/tr>\n
10:40:41PM<\/span><\/td>\nFTSE<\/span><\/td>\n8221.4<\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nShambles<\/span><\/td>\n<\/tr>\n
10:44:20PM<\/span><\/td>\nSTOX50<\/span><\/td>\n4912.6<\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nSuccess<\/span><\/td>\n<\/tr>\n
10:47:17PM<\/span><\/td>\nGERMANY<\/span><\/td>\n18140<\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nSuccess<\/span><\/td>\n<\/tr>\n
10:50:18PM<\/span><\/td>\nUS500<\/span><\/td>\n5468.2<\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
10:53:14PM<\/span><\/td>\nDOW<\/span><\/td>\n39081<\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
10:57:17PM<\/span><\/td>\nNASDAQ<\/span><\/td>\n19690.8<\/span><\/td>\n19643<\/span><\/td>\n19604<\/span><\/td>\n19535<\/span><\/td>\n19766<\/span><\/td>\n19817<\/span><\/td>\n19888<\/span><\/td>\n20031<\/span><\/td>\n19679<\/span><\/td>\nShambles<\/span><\/td>\n<\/tr>\n
10:59:59PM<\/span><\/td>\nJAPAN<\/span><\/td>\n39439<\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n‘cess<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

26\/06\/2024 FTSE Closed at 8225 points. Change of -0.27%. Total value traded through LSE was: \u00a3 5,620,185,904 a change of 8.13%<\/h5>\n
25\/06\/2024 FTSE Closed at 8247 points. Change of -0.41%. Total value traded through LSE was: \u00a3 5,197,523,885 a change of -1.46%<\/h5>\n
24\/06\/2024 FTSE Closed at 8281 points. Change of 0.53%. Total value traded through LSE was: \u00a3 5,274,668,036 a change of -64.96%<\/h5>\n
23\/06\/2024 FTSE Closed at 8237 points. Change of -0.42%. Total value traded through LSE was: \u00a3 15,052,828,026 a change of 169.21%<\/h5>\n
20\/06\/2024 FTSE Closed at 8272 points. Change of 0.82%. Total value traded through LSE was: \u00a3 5,591,583,637 a change of 26.19%<\/h5>\n
19\/06\/2024 FTSE Closed at 8205 points. Change of 0.17%. Total value traded through LSE was: \u00a3 4,431,021,762 a change of -14.42%<\/h5>\n
18\/06\/2024 FTSE Closed at 8191 points. Change of 0.6%. Total value traded through LSE was: \u00a3 5,177,578,584 a change of -3.32% <\/a><\/h5>\n

SUCCESS above means both FAST & SLOW targets were met. ‘CESS means just the FAST target met and probably the next time it is exceeded, movement to the SLOW target shall commence.<\/span><\/span><\/p>\n

Our commentary is in two sections. Immediately below are today’s updated comments. If our commentary remains valid, the share can be found in the bottom section which has a RED heading. Hopefully, this will mean you no longer need to flip back through previous reports. HYPERLINKS DISABLED IN THIS VERSION <\/span><\/span><\/p>\n

Please remember, all prices are mid-price (halfway between the Buy and Sell). When we refer to a price CLOSING above a specific level, we are viewing the point where we can regard a trend as changing. Otherwise, we are simply speculating on near term trading targets. Our website is www.trendsandtargets.com.<\/span><\/span><\/p>\n

UPDATE. We often give an initial and a secondary price. If the initial is exceeded, we still expect it to fall back but the next time the initial is bettered, the price should continue to the secondary. The converse it true with price drops.<\/span><\/span><\/p>\n

We can be contacted at info@trendsandtargets.com. Spam filters set to maximum so only legit emails get through…<\/p>\n

\n

Section One – Outlook Updated Today. Click here for Section Two – Outlook Remains Valid shares<\/h4>\n

<\/a>Click Epic to jump to share: LSE:AZN Astrazeneca** **LSE:BME B & M** **LSE:CCL Carnival** **LSE:JET Just Eat** **LSE:OCDO Ocado Plc** **<\/p>\n

********<\/p>\n

Updated charts published on : Astrazeneca, B & M, Carnival, Just Eat, Ocado Plc,<\/p>\n

\n

LSE:AZN Astrazeneca<\/span>. Close Mid-Price: 12556 Percentage Change: + 0.05% Day High: 12704 Day Low: 12472<\/h4>\n

Further movement against Astrazeneca ABOVE 12704 should improve accelerat ……..<\/span><\/p>\n

Subscribe for more<\/a><\/p>\n

<\/p<\/p>\n

View Previous Astrazeneca & Big Picture ***<\/a><\/p>\n

\n

LSE:BME B & M Close Mid-Price: 452.7 Percentage Change: -0.85% Day High: 463.5 Day Low: 451.6 <\/span><\/h4>\n

If B & M experiences continued weakness below 451.6, it will invariably l ……..<\/span><\/p>\n

Subscribe for more<\/a><\/p>\n

<\/p<\/p>\n

View Previous B & M & Big Picture ***<\/a><\/p>\n

\n

LSE:CCL Carnival<\/span>. Close Mid-Price: 1312.5 Percentage Change: + 4.92% Day High: 1313.5 Day Low: 1223.5<\/h4>\n

Target met. All Carnival needs are mid-price trades ABOVE 1313.5 to impro ……..<\/span><\/p>\n

Subscribe for more<\/a><\/p>\n

<\/p<\/p>\n

View Previous Carnival & Big Picture ***<\/a><\/p>\n

\n

LSE:JET Just Eat Close Mid-Price: 980 Percentage Change: -4.48% Day High: 1042 Day Low: 975 <\/span><\/h4>\n

If Just Eat experiences continued weakness below 975, it will invariably ……..<\/span><\/p>\n

Subscribe for more<\/a><\/p>\n

<\/p<\/p>\n

View Previous Just Eat & Big Picture ***<\/a><\/p>\n

\n

LSE:OCDO Ocado Plc Close Mid-Price: 281 Percentage Change: -3.24% Day High: 297.9 Day Low: 281.5 <\/span><\/h4>\n

Weakness on Ocado Plc below 281.5 will invariably lead to 259p with secon ……..<\/span><\/p>\n

Subscribe for more<\/a><\/p>\n

<\/p<\/p>\n

View Previous Ocado Plc & Big Picture ***<\/a><\/p>\n

\n

*** End of “Updated Today” comments on shares<\/span><\/h2>\n","protected":false},"excerpt":{"rendered":"

#Gold #Nasdaq\u00a0\u00a0Something quite distressing seems to be taking place with cancers. As a child, there was a “bogeyman” number tossed around by the media which suggested 1 in 10 people could experience cancer. Through the years, this was modified to 1 in 5, then 1 in 3 and now 1 in 2 folk will get … <\/p>\n

Continue reading “Avacta Group Plc (LSE:AVCT) around 45 at time of writing”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5077","post","type-post","status-publish","format-standard","hentry","category-trendsandtargets"],"_links":{"self":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/5077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/comments?post=5077"}],"version-history":[{"count":1,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/5077\/revisions"}],"predecessor-version":[{"id":5078,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/5077\/revisions\/5078"}],"wp:attachment":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/media?parent=5077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/categories?post=5077"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/tags?post=5077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}